Semler Scientific Inc. (NASDAQ:SMLR – Get Free Report)’s share price dropped 4.9% on Monday . The company traded as low as $20.27 and last traded at $20.33. Approximately 1,624,100 shares traded hands during trading, an increase of 192% from the average daily volume of 557,094 shares. The stock had previously closed at $21.37.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Semler Scientific in a report on Monday, December 29th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Semler Scientific currently has a consensus rating of “Moderate Buy” and an average price target of $75.33.
View Our Latest Stock Report on Semler Scientific
Semler Scientific Price Performance
Semler Scientific (NASDAQ:SMLR – Get Free Report) last issued its earnings results on Wednesday, November 12th. The company reported $1.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $1.21. Semler Scientific had a return on equity of 34.21% and a net margin of 130.80%.The business had revenue of $7.49 million during the quarter, compared to the consensus estimate of $7.87 million.
Institutional Investors Weigh In On Semler Scientific
Institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada increased its holdings in shares of Semler Scientific by 101.2% in the 1st quarter. Royal Bank of Canada now owns 43,977 shares of the company’s stock valued at $1,592,000 after purchasing an additional 22,123 shares in the last quarter. AQR Capital Management LLC grew its position in Semler Scientific by 71.7% during the first quarter. AQR Capital Management LLC now owns 15,251 shares of the company’s stock worth $552,000 after buying an additional 6,371 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Semler Scientific by 47.1% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,965 shares of the company’s stock worth $144,000 after buying an additional 1,269 shares during the period. Generali Asset Management SPA SGR purchased a new position in Semler Scientific in the second quarter valued at about $2,712,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of Semler Scientific during the 2nd quarter valued at approximately $492,000. 49.37% of the stock is currently owned by hedge funds and other institutional investors.
About Semler Scientific
Semler Scientific, Inc, headquartered in Princeton, New Jersey, is a medical technology company specializing in the development and commercialization of non-invasive monitoring solutions for intracranial pressure. The company’s core focus is on improving patient care in neurocritical and acute care settings by providing clinicians with advanced diagnostic tools that reduce the risks associated with invasive procedures.
The company’s flagship product, the NICO Monitor, employs proprietary acoustic monitoring technology to continuously estimate intracranial pressure and compliance at the bedside.
Recommended Stories
- Five stocks we like better than Semler Scientific
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- End of America Update
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
